NK1 receptor blockade disrupts microtumor growth and aggregation in a three-dimensional murine breast cancer model

• Published in: Neuropeptides (Edinburgh) Vol. 109; p. 102479
• Main Authors: Gutierrez, Silvia, Boada, M. Danilo
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.01.2025
• Subjects: Aprepitant; Breast cancer; Microtumors; Neuropeptides; NK1R; Substance P; Aprepitant; Neuropeptides; NK1R; Breast cancer; Substance P; Microtumors
• ISSN: 0143-4179; 1532-2785; 1532-2785
• DOI: 10.1016/j.npep.2024.102479

Several data indicate that Substance P (SP) neurokinin type 1 receptor (NK1R) is at the center of the interaction between cancer cells and peripheral sensory neurons. Selecting the appropriate cancer cell line and its susceptibility to being modulated by NK1 antagonists are critical to studying this complex interaction. In the current study, we have focused on this selection by comparing several aspects of the triple-negative breast cancer (TNBC) cell line (MDA-MB-231LUC+) with a modified murine cell line (E0771LUC+), both expressing luciferase. This comparison was made using several methods, SP stimulation and 3D cell culture models, to better reproduce the heterogenous microenvironment of solid tumors observed in vivo. Furthermore, the susceptibility of the murine cell line (E0771LUC+) to NK1R antagonist (Aprepitant) was tested. Our results indicate that E0771LUC+ recapitulates several essential aspects of the human cell line, rendering this murine line ideal to be used on immune-competent animals during in vivo studies. We have also found that both cell lines are susceptible to SP stimulation, and their proliferation is disrupted by NK1R antagonists (Aprepitant). In vivo studies are required to verify and refine these findings. [Display omitted] •SP and NK1R are key players driving the interaction between peripheral sensory neurons and cancer cells.•NK1R is present in both breast cancer cell lines.•SP induces breast cancer cell line proliferation, and an NK1R antagonist disrupts it.•Aprepitant alters E0771LUC+ 3D organization, causing size reduction and de-aggregation.